BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Telik, Inc. 

3165 Porter Drive

Palo Alto  California  94304  U.S.A.
Phone: 650-845-7700 Fax: 650-845-7800


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery





 Company News
Telik, Inc. (TELK) Announces Third Quarter 2013 Financial Results 11/13/2013 9:06:24 AM    More...
Telik, Inc. (TELK) Announces Second Quarter 2013 Financial Results 8/12/2013 6:19:12 AM    More...
Telik, Inc. (TELK) Announces First Quarter 2013 Financial Results 5/13/2013 6:24:52 AM    More...
Telik, Inc. (TELK) Announces Fourth Quarter and 2012 Year End Financial Results and 2013 Financial Guidance 3/14/2013 9:52:17 AM    More...
Telik, Inc. (TELK) Announces Preliminary Agreement on Design of Phase 3 Registration Trial of Telintra® in Low to Intermediate-1 Risk Myelodysplastic Syndrome 1/23/2013 8:53:40 AM    More...
Telik, Inc. (TELK) Announces Orphan Designation of Telintra® for Treatment of Myelodysplastic Syndrome 1/14/2013 9:06:51 AM    More...
Telik, Inc. (TELK) Announces Telintra® Clinical Publication at the 54th Annual Meeting of the American Society of Hematology 12/13/2012 9:15:58 AM    More...
Telik, Inc. (TELK) Announces Third Quarter 2012 Financial Results 11/12/2012 9:27:53 AM    More...
Telik, Inc. (TELK) Announces Second Quarter 2012 Financial Results 8/13/2012 9:50:00 AM    More...
Telik, Inc. (TELK) Announces the Publication of Two Reports in the Journal of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Telintra in Patients With Myelodysplastic Syndrome 5/15/2012 10:45:39 AM    More...
12345678910...